1 recruiting, 1 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 1, Unknown 1 |
Follow Peripheral Arterial Occlusive Disease: new trials by email Literature Review of Peripheral Arterial Occlusive Disease trials Research Report on Peripheral Arterial Occlusive Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease Vumerity, Placebo - Peripheral Artery Disease, Peripheral Vascular Diseases | Early Phase 1 | Recruiting | University of Nebraska | 20 | 2024-11-14 | 2026-06-24 |
| Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) [89Zr]Zr-DFO-APAC, PET/CT scan - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia | Early Phase 1 | Unknown | Aplagon Oy | 10 | 2024-02-01 | 2025-01-30 |
Peripheral Arterial Occlusive Disease 1 (2) · Chronic Limb-Threatening Ischemia (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1)
Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Ischemia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1)
Aplagon Oy (1) · University of Nebraska (1)
Netherlands (1) · United States (1)
Gwenael Layec, PhD (1) · Schelto Kruijff, MD, Prof (1)
2023 (1)